miR-223 targeted the 3 ’-UTR of ARRB1 to inhibit ARRB1 expression and effectively antagonized the tumor suppressive effect of ARRB1 in T-ALL (Shu et al., 2019). This evidence concerns the gene ARRB1 and acute lymphoblastic leukemia.